WHC is still in active development. Read this to understand our approach.
depiction of DULCUDSUACXJJC-UHFFFAOYSA-N.svg
isomerdesign

Ethylphenylacetate

Verificar en isomerdesign

pubchem

Ethyl phenylacetate

Verificar en pubchem

Data

InChI: InChI=1S/C10H12O2/c1-2-12-10(11)8-9-6-4-3-5-7-9/h3-7H,2,8H2,1H3

Sinónimos: Ethyl 2-phenyl acetate,NSC 406259,alpha -toluic acid, ethyl ester,CHEBI:180411,ETHYL PHENYLACETATE [INCI],UNII-V6CNZ04D8O,CS-W016087,P0122,NSC8894,Phenylacetic acid ethyl ester,A800492,Tox21_300810,Q27291591,V6CNZ04D8O,Benzene acetic acid ethyl ester,Ethyl phenylethanoate,ETHYL PHENYLACETATE [FHFI],alpha-Toluic acid, ethyl ester,Ethyl alpha-toluate,ETHYL PHENYLACETATE [MI],2-Phenylacetic acid ethyl ester,FEMA No. 2452,Ethyl phenylacetate, ReagentPlus(R), 99%,NSC-8894,HSDB 8382,NSC-406259,Acetic acid, phenyl-, ethyl ester,ethyl 2-phenylacetate,Phenylacetic acid, ethyl ester,SCHEMBL112999,AKOS000120516,4-09-00-01618 (Beilstein Handbook Reference),DTXSID6044353,101-97-3,Phenyl-acetic acid ethyl ester,DSSTox_CID_24353,D77783,DSSTox_GSID_44353,ZINC388060,ethyl-2-phenylacetate,MFCD00009178,Benzeneacetic acid, ethyl ester,WLN: 2OV1R,.alpha.-Toluic acid, ethyl ester,FEMA 2452,HY-W015371,FT-0626358,F0001-0055,EINECS 202-993-8,Ethyl Phenyl Aacetate,ETHYL .ALPHA.-PHENYLACETATE,phenylacetic acid ethyl,Ethyl benzeneacetate,Ethyl phenacetate,CAS-101-97-3,NCGC00248178-01,BRN 0509140,PHENYL ACETIC ACID ETHYL ESTER,Ethyl phenylacetate, natural, 98%, FG,Ethyl phenylacetate, >=98%, FCC, FG,Ethyl alpha -toluate,ETHYL PHENYLACETATE [FCC],ethyl phenyl acetate,Ethyl phenylacetate, Vetec(TM) reagent grade, 97.5%,ETHYL PHENYLACETATE,Ethyl phenylacetate, analytical standard,AI3-00654,EC 202-993-8,PHENYL-ACETIC ACID,ETHYL ESTER,Ethylphenylacetate,CHEMBL3183476,NSC406259,Ethyl .alpha.-toluate,NCGC00254714-01,DB-002721,Ethyl 2-phenylethanoate,DSSTox_RID_80162,Phenyl-acetic acid, ethyl ester


Estimated data

Solubilidad: -1.971 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 56.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.